Therapeutical use of (1-cinnamoyl or 1-phenethylcarbonyl) piperazine derivatives
US4500531A · kind A · utility
1Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 27, 1983 |
| Grant date | Feb 19, 1985 |
| Priority date | — |
| Expiry date | Jul 27, 2003 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A class of known (1-cinnamoyl or 1-phenylethylcarbonyl) piperazine derivatives have been found to be central nervous system stimulants effective to improve the mental alertness and to brighten the spirits of human beings.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.